Dose-Dependent Response to Intramuscular Botulinum ToxinType A for Upper-Limb Spasticity in Patients After a Stroke: Childers MK et al.

Objective: To test the hypothesis that intramuscular (IM) botulinum toxin type A (BTX) reduces excessive muscle tone in a dose-dependent manner in the elbow, wrist, and fingers of patients who experience spasticity after a stroke. …

 

doi:10.1016/j.apmr.2003.10.015

 

Autoren:
Martin K. Childers, DO, PhD, Allison Brashear, MD, Patricia Jozefczyk, MD, Michael Reding, MD,
 David Alexander, MD, David Good, MD, Jennifer M. Walcott, MS, S.W. Jenkins, MD,Catherine Turkel, PharmD, Patricia T. Molloy, MD

 

Autoren-Details
From the University of Missouri-Columbia, Columbia, MO (Childers); IndianaUniversity Hospital, Indianapolis, IN (Brashear); Drexler University College of Medicine, Pittsburgh, PA (Jozefczyk); Burke Stroke Rehabilitation Unit, WhitePlains, NY (Reding); Daniel Freeman Hospital, Inglewood, CA (Alexander); WakeForest University School of Medicine, Winston-Salem, NC (Good); Allergan Inc, Irvine, CA (Walcott, Turkel, Molloy); and Mission Viejo, CA (Jenkins).

 

Bitte hier klicken!